Time course from first symptom to treatment in patients with non-small cell lung referred for radiotherapy: A report by the CHART Steering Committee

Thorax

Volumn 51, Issue 12, 1996, Pages 1262-1265

  Dische, S ^b   Gibson, D ^b   Parmar, M ^a   Saunders, M I ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b NONE

Author keywords

CHART; non small cell lung cancer; radiotherapy; time to treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOTHERAPY; SYMPTOM;

EID: 0029842703     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.12.1262     Document Type: Article

References (11)

1. Cancer Research Campaign Factshecr 5.2. Cancer in the European Community: 1992 .
2. Standing Medical Advisory Committee Report on Working Party chaired by Whitehouse JMA. Management of lung cancer: current clinical practices. 1994.
3. Edinburgh Lung Group. Patients presenting with lung cancer in South East Scotland. Thorax 1987;42:843-7.
4. Cancer Research Campaign Factshect 11.5. Lung cancer and smoking. 1992.
5. Noordijk EM, Poest Clement EVD, Hermans J, Wever AMJ, Leer WJH. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 1988;13:83-9.
6. Saunders MI, Lyn BE, Dische S, Continuous, hyper-fractionated, accelerated radiotherapy (CHART) in non-small cell lung cancer. Lung Cancer 1993;9:221-8.
7. Saunders MI, Dische S, Barrett A, Parmar MBK, Harvey A, Gibson D. Randomised multicentre trials of CHART versus conventional radiotherapy in head and neck and non-small cell lung cancer. An interim report. Br J Cancer 1996;73:1455-62.
8. Weiss W. Peripheral measurable bronchogenic carcinoma. Am Rev Respir Dis 1971;103:198-208.
9. Steele JD, Buell P. Asymptomatic solitary pulmonary nodules - host survival, tumour site and growth rate. J Thorac Cardiovasc Surg 1971;65:140-51.
10. Medical Research Council. Inoperable non-small cell lung cancer. Medical Research Council randomised trial of palliative radiotherapy with two fractions or 10 fractions. Br J Cancer 1991;63:265-70.
11. Medical Research Council. Medical Research Council randomised trial of palliative radiotherapy with two tractions or a single fraction in patients with inoperable non-small cell lung cancer and poor performance status. Br J Cancer 1992;65-934-41.